Listen to this article
Quick Summary
|
What Works |
What Doesn’t |
|---|---|
| A headline long-term track record: 19.7% CAGR since inception (Sept 2015) against the benchmark’s 13.7%, with positive alpha showing up across every disclosed trailing period. |
That 19.7% number was largely built under a different mandate, in a different market, before the strategy was soft-closed to new investors for roughly seven to eight years — the mandate being sold today is a fresh re-launch, not a continuation. |
|
An honest, explicit risk disclosure: the firm openly states that drawdowns in this small and mid-cap approach are “not only possible but frequent,” and sets a clear minimum 5+ year horizon. |
Portfolio holdings, sector weights, stock count, and standard risk metrics (Sharpe ratio, Beta, standard deviation) are all undisclosed in the reviewed materials — an investor today cannot independently verify overlap, concentration, or risk. |
| A clearly capped, enforceable mandate for the relaunch: minimum 75% small and mid-cap exposure, large-cap capped at 25% — a real structural rule, not a vague label. |
The fee structure — fixed fee, variable fee, hurdle rate, profit share, and exit load — is not disclosed anywhere in the materials reviewed, a meaningful gap against standard industry disclosure norms. |
|
Backed by an established 25-year firm with a genuine specialist research orientation — on-ground diligence in under-researched, overlooked segments of the market. |
Benchmarked against the mid-cap active mutual fund category average rather than an index, APJ 20’s long-term edge narrows to near-negligible, and it has actually trailed the category average over the more recent 5-year window. |
Our Verdict: Unifi Capital’s APJ 20 carries a headline track record that looks compelling on the surface, but that number was largely earned by a different mandate, in a different market, before the strategy went quiet for the better part of a decade.
Before paying a PMS-level fee for its re-launch, you deserve to see the holdings, the costs, and the person actually making the calls — none of which the reviewed materials disclose.
Table of Contents
2. Who This PMS May Still Suit
3. Who Should Likely Avoid This PMS
4. What Is Unifi Capital’s APJ 20?
8. The Zero-Based Thinking Test
11. The Core Portfolio Architecture Question
12. What a Genuinely Complementary PMS Looks Like
1. Who Should Read This
Are you looking at APJ 20 because of its striking 19.7% since-inception number, without yet asking what that number actually represents? This article is written for you.
- You currently hold, or are being pitched, the Unifi Capital APJ 20 portfolio and want to understand exactly what you’d be buying into today.
- You are a high-net-worth investor drawn to the headline track record and want to know how much of it is repeatable, going forward, under the mandate being sold now.
- You want a plain, evidence-based answer to a simple question: does this PMS’s fee structure and disclosure standard meet the bar you’d expect before committing ₹50 lakh or more.
- You already hold a diversified mutual fund portfolio and want to know whether a small and mid-cap PMS like this genuinely adds something new, or simply duplicates a slice of what you already own.
- You are comfortable reading performance data critically and want the gaps in disclosure — not just the headline numbers — laid out plainly.
2. Who This PMS May Still Suit
This isn’t a blanket case against the strategy for every investor. Here is who it may genuinely still work for.
- Investors with a genuine 7-10 year horizon who are comfortable backing a concentrated, discovery-oriented small and mid-cap approach and can tolerate frequent, sometimes sharp, drawdowns along the way.
- Investors who value Unifi Capital’s broader 25-year track record and specialist, on-ground research orientation, and are willing to extend some benefit of the doubt to a re-launched mandate on that basis.
- Investors who are comfortable requesting and independently verifying holdings, fees, and risk metrics directly from the fund house before committing — rather than relying solely on the publicly available factsheet.
- Investors allocating a genuinely small, deliberate satellite sleeve of their portfolio to a high-conviction, thematically differentiated strategy, who won’t be meaningfully hurt if the re-launch takes several years to find its footing.
3. Who Should Likely Avoid This PMS
On the other hand, if any of the following describe you, the case for waiting — or looking elsewhere — is considerably stronger.
- You are relying on the 19.7% since-inception figure as a like-for-like preview of what the re-launched mandate will deliver — it isn’t one, given the strategy’s sector focus, market period, and capital-deployment discipline have all changed since that number was largely built.
- You need full transparency on holdings, sector exposure, and fees before you invest, as a matter of process — this PMS’s public disclosure does not currently meet that bar.
- You need this capital within the next 3-5 years — the firm itself states that drawdowns in this segment are frequent, and the strategy explicitly assumes a much longer horizon.
- You cannot currently name who is making the day-to-day investment decisions for this strategy — the available materials name a research team member who assists the CIO, not a publicly identified lead decision-maker.
4. What Is Unifi Capital’s APJ 20?
Before deciding anything, you need to know exactly what’s on offer.
Here are the facts as disclosed.
| Particular | Detail |
|---|---|
|
PMS Name |
APJ 20 |
| Portfolio Manager |
Unifi Capital Pvt Ltd |
|
Fund Manager (as disclosed) |
Mr Baidik Sarkar — Chartered Accountant, 12+ years in consulting, corporate finance and equity research; with Unifi for 10 years; assists the CIO in managing the firm’s Spin-Off and APJ strategies. The CIO with final decision authority is not named in the reviewed materials. |
| Inception Date |
2 September 2015 (approximately 10 years, 9 months old as of the latest disclosure) |
|
Benchmark |
S&P BSE 500 TRI |
| Category |
Small & Mid Cap (platform-tagged as Mid Cap) |
|
Minimum Investment |
₹50,00,000 |
| Assets Under Management (APJ 20) |
Approximately ₹900 crore (as on 30 June 2026) |
|
Firm-wide AUM (Unifi Capital) |
Approximately ₹19,564 crore (USD 2,068 million), across all strategies |
| Portfolio Holdings, Sector Weights, Stock Count |
Not disclosed in the reviewed materials |
|
SIP / STP |
Available |
Here’s what makes this one different from a typical PMS review: APJ 20 was launched in 2015 to identify small and mid-sized businesses at growth inflection points, concentrated originally in five “legacy” sectors — Agriculture & Food Processing, Specialty Chemicals, Specialty Manufacturing, Infrastructure Value Chain, and Mining/Metals.
By 2017-2018, the strategy had reached what the firm itself calls an “advanced deployment phase” — fully allocated, high-conviction, and, in the firm’s words, showing valuations that no longer justified fresh capital.
Rather than dilute returns by deploying new money at unfavourable prices, Unifi made a deliberate decision to soft-close APJ to new investors and shift into pure capital stewardship of the positions already held.
That closed period lasted roughly seven to eight years.
The firm is now re-opening the strategy, targeting an incremental raise of approximately ₹400 crores, under a refreshed mandate: minimum 75% exposure to small and mid-caps, large-cap allocation capped at 25%, and a new set of “focus areas” — Diversified Manufacturing, Digital Economy, Healthcare, and Financial Inclusion — that only partially overlap with the original five sectors the track record was built on.
5. The PMS Value Framework
Before anything else, ask the one question every PMS should have to answer: is the manager adding more value than they charge you for it?
| Zone | Definition |
|---|---|
|
Value Added |
Gross Alpha > Fee — the manager’s skill exceeds what you pay for it. |
| Break-Even |
Gross Alpha ≈ Fee — you are roughly paying for what you get, no more. |
|
Value Destroyed |
Gross Alpha < Fee — the fee is eroding capital faster than the manager is adding it. |
Where does APJ 20 sit today? Measured against its own chosen benchmark, the picture looks strong: +6.0% alpha since inception (19.7% versus 13.7%).
On that basis alone, even a fairly high PMS fee would likely clear the value-added bar.
But here’s the catch — the fee itself isn’t disclosed anywhere in the reviewed materials, so this framework can’t actually be applied with real numbers.
And when you swap the benchmark for a more realistic yardstick — what an investor could have earned in an averagely-managed, low-cost mid-cap mutual fund over the same window — the picture changes.
The mid-cap mutual fund category has delivered a roughly 19.4% CAGR over the past 10 years and 15.77% over the past 5, both figures net of the mutual fund’s own costs.
Against those, APJ 20’s edge all but disappears over the long run, and reverses over the more recent 5-year window.
So which zone does this PMS sit in? Against its own benchmark: value added.
Against the realistic alternative most investors actually have access to — a well-run mid-cap mutual fund — the honest answer is closer to break-even at best, and potentially value-destroyed once you factor in a PMS fee that, going by industry norms, likely runs meaningfully higher than a mutual fund’s expense ratio.
6. Performance Review
When did you last actually check whether this PMS’s headline number reflects the strategy you’re being asked to invest in today — not the one that existed a decade ago?
Trailing Returns Vs Benchmark (as disclosed)
| Period | APJ 20 | S&P BSE 500 TRI | Alpha (+/-) |
|---|---|---|---|
| 1 Year | -1.31% | -1.96% | +0.65% |
| 2 Year | 2.97% | 1.52% | +1.45% |
| 3 Year | 14.01% | 12.53% | +1.48% |
| 5 Year | 13.64% | 12.21% | +1.43% |
| Since Inception | 19.7% | 13.7% | +6.0% |
A note on this table: the 1-2-3-5 year figures are read from the fund house’s published performance chart; the Since Inception figures come from the firm’s own separately stated CAGR (₹100 invested growing to ₹702 for APJ 20 versus ₹401 for the benchmark, as on 30th June 2026).
Both sources agree closely on the Since Inception number, which is why it anchors this review — but note how much thinner the alpha is over 3 and 5 years (roughly +1.4 to +1.5 percentage points) compared with the headline Since Inception figure (+6.0 points). That gap tells its own story.
Calendar Year Performance
| Calendar Year | APJ 20 Return |
|---|---|
| CY 2024 | 14.03% |
| CY 2025 | Negative (small decline; precise figure not clearly legible in the disclosed chart) |
| CY 2026 YTD | 2.29% |
Here’s the thing.
Look at that Since Inception alpha of +6.0% again, and then look at the 3-year and 5-year alpha sitting at roughly a third of that, at +1.48% and +1.43%.
That’s not a contradiction — it’s arithmetic.
A large chunk of the outperformance embedded in the “since inception” number was earned in the strategy’s early years, when it was fully deployed in a different set of sectors, under different market conditions, by a fully-invested high-conviction portfolio that was then left largely untouched during the multi-year soft-close.
The more recent trailing windows — the ones that actually reflect how the strategy has performed lately, closer to the market conditions a new investor is stepping into today — show a much thinner edge.
Is there a legitimate explanation for the reversal in the sector mix — from Chemicals-led returns in 2016-2020 to Banking Services and Software & IT-led returns in 2021-2025?
Yes, and the firm states it plainly: as chemical-sector valuations stretched without a matching improvement in return on capital, the team held back rather than chase, and let the portfolio’s centre of gravity shift.
That’s a defensible, even prudent, response to a valuation cycle.
But it’s also, by definition, a materially different portfolio than the one an investor bought into in 2016 — and now, in 2026, a third sector rotation is being proposed, into Diversified Manufacturing, Digital Economy, Healthcare and Financial Inclusion, sectors that haven’t yet been tested with real capital under this strategy’s own track record.
Is the long-term outperformance temporary or structural? Honestly, this is close to unanswerable with the data disclosed.
What can be said plainly is that the mandate you’d be buying into today has not yet generated a standalone track record of its own — you’d be extending trust based on a number earned under different conditions, by a portfolio that no longer exists in its original form.
7. The Fee Reality
If you can’t see the fee structure before you invest, how exactly are you supposed to judge whether it’s worth paying?
Fee Structure
| Component | Detail |
|---|---|
|
Fixed Fee |
Not disclosed in the reviewed materials |
| Variable Fee / Hurdle / Profit Share |
Not disclosed in the reviewed materials |
|
Exit Load |
Not disclosed in the reviewed materials |
This is worth sitting with. Every other PMS factsheet reviewed in this series discloses its fixed fee, its variable fee structure (including hurdle rate and profit share), and its exit load schedule as standard practice. APJ 20’s publicly available disclosure does not.
That doesn’t necessarily mean the fee is unreasonable — it means you cannot know, from the materials available to a prospective investor, whether it is or isn’t. That’s a due-diligence gap you should close directly with the fund house, in writing, before committing capital.
Fee Drag on ₹50 Lakhs: The Rupee Picture
Since the actual PMS fee isn’t disclosed, this comparison uses APJ 20’s disclosed returns (presumed net of whatever fee applies, per standard industry TWRR disclosure convention) against the mid-cap active mutual fund category average — a fair, apples-to-apples “net versus net” comparison, since MF category returns are also already net of that category’s own costs.
| Scenario | Net Return Assumed (Estimated) | Corpus After 5 Years | Corpus After ~10 Years (Since Inception) |
|---|---|---|---|
|
APJ 20 (Net, as disclosed) |
13.64% (5Y) / 19.7% (Since Inception) | ≈ ₹94.8 lakh | ≈ ₹3.02 crore |
| Mid-Cap Category Average (Active MFs, Net, approximate) | ≈15.77% (5Y) / ≈19.4% (10Y) | ≈ ₹1.04 crore |
≈ ₹2.94 crore |
Read that 5-year row again. On the most recent, most relevant window, the average mid-cap mutual fund — available with daily liquidity, mandatory monthly portfolio disclosure, a named fund manager, and typically a lower cost structure — has put roughly ₹9 lakhs more in an investor’s pocket on a ₹50 lakh allocation than APJ 20 has, before any PMS fee is even applied.
Over the full since-inception window, APJ 20 does come out ahead — by about ₹8 lakhs on the same ₹50 lakh, or roughly 2.7% cumulative over a decade.
That’s a thin enough margin that a PMS fee running anywhere near industry-typical levels would very plausibly erase it entirely.
8. The Zero-Based Thinking Test
Here’s the question that cuts through everything else: knowing everything you know today — including the soft-close history, the undisclosed fees, and the undisclosed holdings — if you were starting fresh with this money right now, would you invest in this same product?
Not “the track record impressed me, so I should stay invested.” Not “I’ve already committed, so backing out feels like giving up on it.”
Just that one clean question, asked as if you were seeing the factsheet for the first time today, in July 2026, with the strategy actively re-opening for fresh capital.
Here’s where it gets uncomfortable. A fresh investor evaluating APJ 20 today isn’t really evaluating a decade of performance.
They’re evaluating a newly re-launched mandate, run by an unnamed decision-maker, with undisclosed holdings and undisclosed fees, whose only public evidence is a track record earned under a different sector focus, in a different market, by a portfolio that was largely left untouched for most of the years in question. Would you commit ₹50 lakhs to a fund on those terms if it didn’t already carry a well-known name and an eye-catching headline number attached to it?
If your honest answer is yes — because you trust the firm’s broader 25-year track record, you’re comfortable with the disclosure gaps, and you have the horizon and temperament for a concentrated small-and-mid-cap approach — that’s a legitimate, considered choice.
If your honest answer is no, or even “I’m not sure,” that hesitation is worth listening to. It isn’t inertia. It’s your own judgment, working correctly.
9. Decision Factor Scorecard
Twelve standard factors, plus one specific to this fund’s unusual history, each rated honestly with the reasoning sitting right next to it.
| Decision Factor | Rating | Analysis |
|---|---|---|
|
1. Uniqueness vs existing MF portfolio |
🟡 | Thematically, a small and mid-cap, discovery-oriented strategy targeting under-researched, overlooked segments is plausibly differentiated from a typical large-cap or flexi-cap mutual fund core holding. But with portfolio holdings and sector weights entirely undisclosed, this cannot actually be verified. You cannot check for overlap against your existing mutual funds because the very information needed to check is not published. |
| 2. Alpha consistency across periods | 🟢 |
On the data disclosed, alpha has been positive across every trailing window shown — 1, 2, 3, 5 years, and since inception — against the S&P BSE 500 TRI. That is a genuinely consistent pattern on paper. The caveat, addressed elsewhere in this review, is that the size of that alpha shrinks considerably in the more recent 3- and 5-year windows compared with the since-inception headline. |
|
3. Justification for PMS premium fee |
🔴 | The fee itself is not disclosed, which alone makes this factor hard to score positively. Using the mid-cap mutual fund category average as a fairer real-world comparison than the fund’s own benchmark, APJ 20’s returns have been roughly in line with category average over 10 years and behind category average over the more recent 5 years — before any PMS fee, which by industry convention typically runs higher than a mutual fund’s expense ratio, is even applied. |
| 4. Downside protection in market corrections | 🟡 |
The firm deserves credit for stating plainly, in its own materials, that drawdowns in this small and mid-cap segment are “not only possible but frequent” — an unusually candid risk disclosure. However, no quantified risk metrics — standard deviation, Sharpe ratio, Beta — are provided for APJ 20 in the reviewed materials, so the actual magnitude of that downside risk cannot be independently assessed. |
|
5. Portfolio complement for MF investor |
🟡 | A concentrated, small/mid-cap, sector-rotating strategy could genuinely complement a diversified large-cap-heavy mutual fund core — in principle. In practice, with holdings undisclosed, an investor has no way to confirm whether this PMS is adding a new return stream or simply duplicating an existing small/midcap mutual fund allocation they may already hold. |
| 6. Mandate purity and discipline | 🔴 |
This strategy’s sector focus has changed materially, and by the firm’s own account, more than once: from an original five-sector focus (Agriculture, Chemicals, Manufacturing, Infrastructure, Mining) that drove returns through 2020, to a Banking Services and Software & IT-led portfolio through 2021-2025, to a newly proposed “New Focus Areas” framework (Diversified Manufacturing, Digital Economy, Healthcare, Financial Inclusion) for the re-launch. The firm frames each shift as a considered, valuation-driven response rather than undisciplined drift, and that framing has some merit — but the practical result is that mandate purity, in the sense of a stable, unchanging thesis, has not been a feature of this strategy’s history. |
|
7. Fund manager transparency |
🔴 | The firm’s narrative-level communication is genuinely good — the presentation reviewed lays out its philosophy, its history, and its risks in clear, candid language. But the hard data that actually matters for evaluating an investment — current holdings, sector weights, fee structure, and quantified risk metrics — is absent. A named research team member (Mr Baidik Sarkar) is disclosed as assisting the CIO, but the CIO who holds final decision-making authority is not named anywhere in the materials reviewed. |
| 8. Investment horizon suitability | 🟢 |
This is a genuine strength. The firm explicitly and repeatedly sets a minimum 5+ year horizon, and frames the relaunched approach around a 7-10-year opportunity in India’s industrial, digital, and healthcare transformation. That candour about the time commitment required is exactly what responsible horizon-setting should look like. |
|
9. Market cap flexibility utilisation |
🟢 | The relaunched mandate sets a clear, enforceable structure: minimum 75% exposure to small and mid-caps, large-cap allocation capped at 25%. This is a real structural constraint rather than a loosely defined label, which is a meaningful positive for mandate clarity going forward. |
| 10. Concentration vs diversification balance | 🔴 |
The firm’s own published Top Sectors data (2016-2025) shows the top 5 sectors have historically contributed between 55% and 80% of the portfolio, frequently above 65-70%. Combined with the explicitly stated philosophy of a “concentrated portfolio approach,” this is a genuinely high-concentration strategy — a deliberate choice, but one that carries real single-theme risk regardless of intent. |
|
11. AUM size and strategy capacity |
🔴 | At roughly ₹900 crores already, and now targeting an incremental raise of approximately ₹400 crores more, total AUM in this small and mid-cap strategy could approach ₹1,300 crore. The firm’s own stated edge rests on finding “under-researched businesses in essential, overlooked segments with limited institutional capital” — precisely the kind of opportunity that becomes harder to access, without moving prices, as AUM in that same segment grows. This is a legitimate tension between the strategy’s stated philosophy and its stated fundraising ambition. |
| 12. Manager tenure and continuity risk | 🔴 |
The strategy has existed since 2015, but was soft-closed to new investors for roughly seven to eight years while in stewardship mode — meaning there has been no continuous, live track record of active decision-making and fresh capital deployment across that period. No single, named lead portfolio manager with public accountability is identified for APJ 20 in the materials reviewed, which makes it difficult to assess individual manager tenure or key-person risk in the way this factor is normally evaluated. |
|
13. Track record relevance to the mandate being sold today (strategy-specific) |
🔴 |
This is the central issue with this specific PMS. The 19.7% since-inception CAGR reflects a portfolio that was largely built and deployed by 2017-2018, under an original five-sector focus, then held with limited fresh capital for roughly seven to eight years. The mandate now being marketed to new investors — a refreshed sector framework, an active fundraising target, and a market environment a decade removed from the strategy’s formative years — does not yet have a standalone track record of its own. An investor evaluating this PMS today is, in effect, being asked to extend the historical number’s credibility to a materially different product. |
10. Summary Scorecard
| Decision Factor | Rating |
|---|---|
|
1. Uniqueness vs existing MF portfolio |
🟡 |
| 2. Alpha consistency across periods |
🟢 |
|
3. Justification for PMS premium fee |
🔴 |
| 4. Downside protection in market corrections |
🟡 |
|
5. Portfolio complement for MF investor |
🟡 |
| 6. Mandate purity and discipline |
🔴 |
|
7. Fund manager transparency |
🔴 |
| 8. Investment horizon suitability |
🟢 |
|
9. Market cap flexibility utilisation |
🟢 |
| 10. Concentration vs diversification balance |
🔴 |
|
11. AUM size and strategy capacity |
🔴 |
| 12. Manager tenure and continuity risk |
🔴 |
|
13. Track record relevance to the mandate being sold today (strategy-specific) |
🔴 |
11. The Core Portfolio Architecture Question
Here’s a question worth asking before anything else: what job would this PMS actually be doing inside your overall portfolio?
A useful way to think about any HNI portfolio is in two layers.
The core is built with low-cost, diversified mutual funds — index funds, flexi-cap and multi-asset funds — designed to capture broad market growth as efficiently and cheaply as possible.
The satellite is a smaller, deliberately chosen sleeve of PMS and AIF strategies, meant to access opportunities your core mutual fund portfolio structurally cannot reach on its own — a specific small-cap universe, a special-situations mandate, a genuinely differentiated factor tilt, or unlisted exposure.
The test for any satellite holding is simple: does it complement your core, or does it quietly duplicate it — and can you even tell the difference?
That second part is the real problem with this particular PMS.
Even if APJ 20’s thematic, discovery-oriented approach is genuinely different from your core mutual funds in principle, the current level of public disclosure makes it impossible to confirm that in practice.
A satellite holding you can’t actually inspect isn’t really serving its architectural purpose — it’s a leap of faith wearing a satellite’s label.
This isn’t a judgment on whether Unifi Capital, as a firm, is well run — its broader 25-year record and research orientation suggest it is.
It’s a question of whether this specific, newly re-launched strategy currently gives you enough information to place it correctly within your own portfolio architecture. On the evidence available, it does not yet.
12. What a Genuinely Complementary PMS Looks Like
Without naming any specific alternative, here is what separates a satellite holding that earns its place from one that doesn’t.
- It discloses its holdings and sector weights clearly enough that you can verify, stock by stock, whether it overlaps with your existing mutual fund portfolio.
- It discloses its fee structure — fixed fee, variable fee, hurdle, profit share, and exit load — as a matter of course, not on special request.
- It generates positive alpha consistently across multiple trailing periods against a realistic, comparable benchmark, not only over a single long since-inception window.
- Its net-of-fee return durably and demonstrably exceeds what a comparable active mutual fund category average delivers, on a rolling basis, not just at one favourable point in time.
- Its track record reflects the mandate you are actually being asked to invest in today, not a materially different mandate the firm has since moved away from.
13. Exit Considerations
This is one area where this review has to be more limited than usual.
The exit load schedule for APJ 20 is not disclosed in the materials reviewed.
Before you invest — or if you are already invested and considering an exit — you should request the exact exit load schedule, in writing, directly from Unifi Capital or your relationship manager, rather than assuming standard industry terms apply.
Tax treatment: PMS structures hold securities directly in your name, which means capital gains are computed and taxed at the individual stock level — every sale within the portfolio, whether triggered by the manager’s rebalancing or your own exit, is a taxable event for you, subject to standard equity LTCG/STCG rules based on each stock’s holding period.
This is structurally different from a mutual fund, where you are only taxed when you redeem your own units, regardless of how much churn happens inside the fund.
A staggered exit — reducing your position over two or three tranches rather than redeeming in a single transaction — can help manage both the (currently undisclosed) exit load timeline and the tax event across financial years, rather than concentrating the entire capital gains liability into one year.
This is worth planning with your tax advisor once the actual exit terms have been confirmed in writing.
14. Key Takeaways
1. APJ 20’s headline 19.7% since-inception CAGR (versus 13.7% for the benchmark) was largely built between 2015 and 2018, under a different sector focus, before the strategy was soft-closed to new investors for roughly seven to eight years.
2. The mandate being sold to new investors today is a re-launch — a refreshed sector focus and an active fundraising target of approximately ₹400 crores incremental capital — without a standalone track record of its own.
3. Alpha over the benchmark has been positive across every disclosed period, but shrinks from +6.0% since inception to roughly +1.4-1.5% over the more recent 3- and 5-year windows.
4. Portfolio holdings, sector weights, stock count, and standard risk metrics (Sharpe, Beta, standard deviation) are undisclosed in the reviewed materials, making independent overlap and risk verification impossible.
5. The fee structure — fixed fee, variable fee, hurdle, profit share, and exit load — is not disclosed anywhere in the materials reviewed.
6. Benchmarked against the mid-cap active mutual fund category average rather than an index, APJ 20’s edge narrows to near-negligible over 10 years and reverses over the more recent 5-year window.
7. Sector concentration has historically been high — the top 5 sectors have contributed 55-80% of the portfolio across 2016-2025 — a deliberate, disclosed choice, but a real risk factor nonetheless.
8. The firm’s honest, explicit disclosure of drawdown risk and its clearly capped market-cap mandate for the relaunch are genuine, creditable strengths worth acknowledging alongside these concerns.
15. Frequently Asked Questions
i. Is Unifi Capital APJ 20 a good PMS?
Unifi Capital APJ 20 has a strong headline long-term return, but that track record was largely built under a different, earlier mandate before a multi-year soft-close. The strategy being sold today is a re-launch without its own standalone track record, and key details — holdings, fees, and risk metrics — are not publicly disclosed, which makes a confident “good” or “bad” verdict difficult to give responsibly.
ii. What is the minimum investment for APJ 20?
The minimum investment is ₹50,00,000, in line with SEBI’s minimum ticket size requirement for portfolio management services.
iii. What are the fees for APJ 20?
The fee structure is not disclosed in the publicly available factsheet reviewed for this article. Prospective investors should request the fixed fee, variable fee (including hurdle rate and profit share), and exit load schedule directly from Unifi Capital before investing.
iv. Who manages APJ 20?
Mr Baidik Sarkar, a Chartered Accountant who has been with Unifi Capital for 10 years, is disclosed as assisting the CIO in managing the strategy. The CIO holding final investment decision-making authority is not named in the reviewed materials.
v. Why was Unifi APJ 20 closed to new investors?
According to the firm’s own account, by 2017-2018 the strategy had reached full deployment with stretched valuations in its focus sectors relative to underlying cash flows and return on capital. Rather than deploy fresh capital at unfavourable prices, the Unifi APJ 20 firm chose to soft-close the strategy and focus on stewarding existing positions.
vi. Is the old track record relevant to a new investor today?
Only partially. The since-inception CAGR reflects a portfolio built under a different sector focus and market environment, largely before the multi-year soft-close. The re-launched mandate — a refreshed sector framework and active fresh fundraising — has not yet built its own independent track record.
vii. What does portfolio overlap mean and why does it matter?
Portfolio overlap refers to how much of a PMS’s holdings you already own, directly or indirectly, through your existing mutual funds. With APJ 20’s holdings undisclosed, this overlap cannot currently be checked — which is itself a material limitation for due diligence.
viii. Should I compare PMS returns to an index fund?
For evaluating manager skill (alpha), a PMS’s own disclosed benchmark index is the appropriate yardstick. For evaluating whether a PMS-level fee is worth paying relative to a professionally managed, lower-cost alternative, comparing net returns against the relevant active mutual fund category average — as this review does — is generally more useful than a product-versus-index comparison.
ix. What should I ask a PMS before investing in a re-launched or newly reopened strategy?
Ask specifically: what has changed in the mandate, sector focus, or team since the track record being shown to you was earned; what the current holdings and fee structure are, in writing; and whether the historical performance was achieved under materially different market-cap, sector, or capital-deployment constraints than what applies going forward.
16. Our Approach
We are a process-driven investment advisory practice, and yes, we do recommend PMS strategies to clients where the evidence supports it — but we don’t recommend this particular one, for the reasons laid out above.
Our role isn’t to sell you a replacement; it’s to help you see your existing PMS and mutual fund holdings side by side, as a Certified Financial Planner would, and understand plainly whether each piece is genuinely complementing your portfolio or quietly overlapping with it.
If you’d like that comparison done for your specific holdings, you’re welcome to reach out for a portfolio review.
Leave a Reply